Filing Details
- Accession Number:
- 0000899866-13-000131
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-16 16:47:56
- Reporting Period:
- 2013-07-12
- Filing Date:
- 2013-07-16
- Accepted Time:
- 2013-07-16 16:47:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899866 | Alexion Pharmaceuticals Inc | ALXN | Pharmaceutical Preparations (2834) | 133648318 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1231954 | P Stephen Squinto | C/O Alexion Pharmaceuticals Inc 352 Knotter Drive Cheshire CT 06410 | Evp, Chief Global Ops. Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value .0001 Per Share | Acquisiton | 2013-07-12 | 6,876 | $17.98 | 115,338 | No | 4 | M | Direct | |
| Common Stock, Par Value .0001 Per Share | Acquisiton | 2013-07-12 | 11,124 | $22.90 | 126,462 | No | 4 | M | Direct | |
| Common Stock, Par Value .0001 Per Share | Disposition | 2013-07-12 | 18,000 | $119.90 | 108,462 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to Purchase Common Stock | Disposition | 2013-07-12 | 6,876 | $17.98 | 6,876 | $17.98 |
| Common Stock, Par Value $.0001 Per Share | Option to Purchase Common Stock | Disposition | 2013-07-12 | 11,124 | $22.90 | 11,124 | $22.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-04-26 | 2019-01-26 | No | 4 | S | Direct |
| 0 | 2010-04-28 | 2020-01-28 | No | 4 | S | Direct |
Footnotes
- The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
Billionaire Hedge Funds
